The recurrent mutation of RHEB Y35 in cancers underscores the importance of this residue, and illustrates that the unique biochemical properties of RHEB lead to a different mutational hotspot relative to RAS, in which the majority of mutations affect G12, G13 and Q61. This evidence concerns the gene RHEB and cancer.